{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:55:34Z","timestamp":1791024934809,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpb.2026.115218","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:21:55Z","timestamp":1787325715000},"page":"115218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted topical delivery of Ruxolitinib-Loaded nanoemulgel for potential management of Atopic Dermatitis: An integrated in silico, in vitro, and in vivo approach"],"prefix":"10.1016","volume":"228","author":[{"given":"Ganesh","family":"Vambhurkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Famta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Phatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etikala","family":"Amulya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4363","authenticated-orcid":false,"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115218_b0005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10787-025-01642-z","article-title":"Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights","volume":"33","author":"Abdel-Mageed","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejpb.2026.115218_b0010","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/all.15721","article-title":"Atopic dermatitis: Correlation of distinct risk factors with age of onset in adulthood compared to childhood, Allergy Eur","volume":"78","author":"Maintz","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2026.115218_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70029","article-title":"Atopic dermatitis: pathogenesis and therapeutic intervention","volume":"5","author":"Yue","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ejpb.2026.115218_b0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40521-020-00271-x","article-title":"Filaggrin Gene Mutations with special Reference to Atopic Dermatitis","volume":"7","author":"Gupta","year":"2020","journal-title":"Curr. Treat. Options Allergy"},{"key":"10.1016\/j.ejpb.2026.115218_b0025","article-title":"An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120591","article-title":"Different molecular weight hyaluronic acid alleviates inflammation response in DNFB-induced mice atopic dermatitis and LPS-induced RAW 264.7 cells","volume":"301","author":"Zheng","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clindermatol.2017.10.002","article-title":"Skin barrier and dry skin in the mature patient","volume":"36","author":"Ton\u010di\u0107","year":"2018","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115218_b0040","article-title":"Topical and conventional Systemic Treatments in Atopic Dermatitis: have they gone out of Fashion?","volume":"12","author":"Calabrese","year":"2022","journal-title":"Dermatology Pract. Concept."},{"key":"10.1016\/j.ejpb.2026.115218_b0045","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4062\/biomolther.2025.081","article-title":"Atopic Dermatitis Management: from conventional Therapies to Biomarker-Driven Treatment Approaches","volume":"33","author":"Lee","year":"2025","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.ejpb.2026.115218_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1068260","article-title":"JAK\u2013STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115218_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ejpb.2026.115218_b0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejpb.2026.115218_b0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","article-title":"JAK-STAT pathway inhibitors in dermatology","volume":"98","author":"Miot","year":"2023","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115218_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104499","article-title":"FDA approves Ruxolitinib (Opzelura) for Vitiligo Therapy: a breakthrough in the field of dermatology","volume":"81","author":"Sheikh","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ejpb.2026.115218_b0075","first-page":"897","article-title":"Systemic Therapy for Atopic Dermatitis in Children and Adolescents: a US Expert Consensus","volume":"240","author":"Eichenfield","year":"2024","journal-title":"Dermatology"},{"key":"10.1016\/j.ejpb.2026.115218_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2020.06.013","article-title":"The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19","volume":"54","author":"Goker Bagca","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejpb.2026.115218_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ph19020247","article-title":"Nanoemulgels as Advanced Topical Drug delivery Systems: Mechanistic Insights and Therapeutic applications in Skin Disorders, Infections, Wound Healing, and Cancer","volume":"19","author":"Jacob","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115218_b0090","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2147\/DDDT.S407475","article-title":"Nano-Emulsion based Gel for Topical delivery of an Anti-Inflammatory Drug: In vitro and in vivo Evaluation","volume":"17","author":"Gaber","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejpb.2026.115218_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120771","article-title":"Topical menthol mitigates pruritus and inhibits spinal microglial activation in mice","volume":"356","author":"Hung","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejpb.2026.115218_b0100","doi-asserted-by":"crossref","unstructured":"B. Bravo, P. Correia, J.E. Gon\u00e7alves Junior, B. Sant\u2019Anna, D. Kerob, Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence, Dermatol. Ther. 35 (2022). Doi: 10.1111\/dth.15903.","DOI":"10.1111\/dth.15903"},{"key":"10.1016\/j.ejpb.2026.115218_b0105","doi-asserted-by":"crossref","unstructured":"S.A. Kleinubing, P.M. Outuki, J. Hoscheid, B.L. Pelegrini, E. Antonio da Silva, J. Renata de Almeida Canoff, M. Miriam de Souza Lima, M.L. Carvalho Cardoso, Hyaluronic acid incorporation into nanoemulsions containing Pterodon pubescens Benth. Fruit oil for topical drug delivery, Biocatal. Agric. Biotechnol. 32 (2021). Doi: 10.1016\/j.bcab.2021.101939.","DOI":"10.1016\/j.bcab.2021.101939"},{"key":"10.1016\/j.ejpb.2026.115218_b0110","doi-asserted-by":"crossref","DOI":"10.1590\/1806-9282.20250208","article-title":"Effects of hyaluronic acid on skin at the cellular level: a systematic review","volume":"71","author":"Karabat","year":"2025","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ejpb.2026.115218_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.124786","article-title":"Hyaluronic acid\u2013butyrate conjugates for barrier restoration in atopic dermatitis: CD44-mediated retention and inflammation-responsive release","volume":"375","author":"Liu","year":"2026","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2026.115218_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142185","article-title":"Development and evaluation of nilotinib-loaded Bovine Serum Albumin nanoparticles: In-vitro and in-silico insights","volume":"308","author":"Shaikh","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115218_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.122870","article-title":"Multimodal lemongrass oil based topical nanoemulgel ingrained with ferulic acid for wound healing activity","volume":"389","author":"Bhavana","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2026.115218_b0130","article-title":"Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2,4-Dichlorodinitrobenzene induced atopic dermatitis in mice model","volume":"80","author":"Atmakuri","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115218_b0135","first-page":"2200","article-title":"Topical delivery of baricitinib-impregnated nanoemulgel: a promising platform for inhibition of JAK -STAT pathway for the effective management of atopic dermatitis, Drug Deliv","volume":"15","author":"Nene","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115218_b0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2006.10.014","article-title":"Development and bioavailability assessment of ramipril nanoemulsion formulation","volume":"66","author":"Shafiq","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115218_b0145","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2184311","article-title":"Utilization of experimental design in the formulation and optimization of hyaluronic acid\u2013based nanoemulgel loaded with a turmeric\u2013curry leaf oil nanoemulsion for gingivitis","volume":"30","author":"Sindi","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115218_b0150","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/10837450.2025.2505004","article-title":"Amelioration of imiquimod-induced psoriasis in the mice model by topical delivery of phosphodiesterase 4 inhibitor roflumilast incorporated nanoemulgel","volume":"30","author":"Prasannanjaneyulu","year":"2025","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2026.115218_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106665","article-title":"Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: Physical characterization and in vivo evaluation","volume":"195","author":"Khan","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0160","unstructured":"O. Ullah Shirazi, M. Muzaffar Ali Khan Khattak, N. Azwani Mohd Shukri, M.A. Mohd Nur Nasyriq, O. Shirazi, M.A. Nur Nasyriq, Determination of total phenolic, flavonoid content and free radical scavenging activities of common herbs and spices, J. Pharmacogn. Phytochem. JPP. 104 (2014) 104\u2013108."},{"key":"10.1016\/j.ejpb.2026.115218_b0165","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.2147\/IJN.S278688","article-title":"Bilosomes as promising nanovesicular carriers for improved transdermal delivery: Construction, in vitro optimization, ex vivo permeation and in vivo evaluation","volume":"15","author":"Ahmed","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115218_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25441","article-title":"Plasticizer\u2013gelatin mixed solutions as skin protection materials with flexible-film-forming capability","volume":"10","author":"Yunoki","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2026.115218_b0175","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5415","article-title":"miR-155 promotes an inflammatory response in HaCaT cells via the IRF2BP2\/KLF2\/NF-\u03baB pathway in psoriasis","volume":"54","author":"Chen","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115218_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121909","article-title":"Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB\/c mice","volume":"328","author":"Singh","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0185","article-title":"Quality by Design Galvanized development of resveratrol loaded PLGA nanoparticles: In vitro and Ex vivo evaluation for the non-invasive treatment of metastatic melanoma","volume":"91","author":"Vambhurkar","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115218_b0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/jidsymp.2009.12","article-title":"Reactive oxygen species in HaCaT keratinocytes after UVB irradiation are triggered by intracellular Ca2+ levels","volume":"14","author":"Masaki","year":"2009","journal-title":"J. Investig. Dermatology Symp. Proc."},{"key":"10.1016\/j.ejpb.2026.115218_b0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.a.10059","article-title":"Sensitive and Reliable JC-1 and TOTO-3 double Staining to Assess Mitochondrial Transmembrane potential and Plasma Membrane Integrity: interest for Cell Death Investigations","volume":"54","author":"Zuliani","year":"2003","journal-title":"Cytom. Part A"},{"key":"10.1016\/j.ejpb.2026.115218_b0200","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10616-017-0125-0","article-title":"Cytotoxicity and apoptotic cell death induced by Vitis vinifera peel and seed extracts in A431 skin cancer cells","volume":"70","author":"Grace Nirmala","year":"2018","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ejpb.2026.115218_b0205","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3892\/mmr.2016.4917","article-title":"Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways","volume":"13","author":"Jing","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejpb.2026.115218_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109398","article-title":"Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK\/NF-\u03baB\/AP-1 activation","volume":"119","author":"Weng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2026.115218_b0215","article-title":"Curcumin loaded liquid crystalline nanoparticles for enhanced topical application: Design, characterization, ex vivo and dermatokinetic evaluation","volume":"92","author":"Tomar","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115218_b0220","article-title":"Evaluation of preclinical efficacy of apremilast-loaded liquid crystalline nanoparticulate gel in amelioration of atopic dermatitis","volume":"96","author":"Nene","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115218_b0225","article-title":"The Skin Histopathology of Pro- and Parabiotics in a Mouse Model of Atopic Dermatitis","volume":"16","author":"Kim","year":"2024","journal-title":"Nutr"},{"key":"10.1016\/j.ejpb.2026.115218_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-018-0104-3","article-title":"Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes","volume":"50","author":"Jang","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115218_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146601","article-title":"Taraxacummongolicum Ameliorates DNCB-Induced Atopic Dermatitis-like Symptoms in mice by Regulating Oxidative stress, Inflammation, MAPK, and JAK\/STAT\/TSLP Signaling Pathways","volume":"26","author":"Jiang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.anai.2023.09.009","article-title":"Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives","volume":"132","author":"Stefanovic","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejpb.2026.115218_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12060893","article-title":"From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine","volume":"12","author":"Maintz","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ejpb.2026.115218_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810466","article-title":"Atomic simulation of the Binding of JAK1 and JAK2 with the Selective Inhibitor Ruxolitinib","volume":"23","author":"Kondratyev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0255","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4298004","article-title":"Quality-by-Design based Fabrication of Febuxostat-Loaded Nanoemulsion: Statistical Optimization, Characterizations, Permeability, and Bioavailability Studies","author":"Gurumukhi","year":"2022","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.ejpb.2026.115218_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081640","article-title":"Fabrication and Optimization of Essential-Oil-Loaded Nanoemulsion using Box\u2013Behnken Design against Staphylococos aureus and Staphylococos epidermidis Isolated from Oral Cavity","volume":"14","author":"Ullah","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115218_b0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/0975-7406.168037","article-title":"Stability studies of silymarin nanoemulsion containing Tween 80 as a surfactant","volume":"7","author":"Parveen","year":"2015","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.ejpb.2026.115218_b0270","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12668-022-00980-4","article-title":"DoE based Formulation Development and Characterization of Topical Nanoemulgel of Diacerein: In-Vitro Release and Permeation Studies","volume":"12","author":"Nishal","year":"2022","journal-title":"BioNanoScience"},{"key":"10.1016\/j.ejpb.2026.115218_b0275","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.matpr.2021.12.038","article-title":"Identification and antioxidant activity of hyaluronic acid extracted from local isolates of Streptococcus thermophilus","volume":"60","author":"Mohammed","year":"2022","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.ejpb.2026.115218_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10071004","article-title":"Mint oils: In vitro ability to perform anti-inflammatory, antioxidant, and antimicrobial activities and to enhance intestinal barrier integrity","volume":"10","author":"Hejna","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115218_b0285","doi-asserted-by":"crossref","DOI":"10.1007\/s00403-024-03003-2","article-title":"Effectiveness of topical hyaluronic acid of different molecular weights in xerosis cutis treatment in elderly: a double-blind, randomized controlled trial","volume":"316","author":"Muhammad","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejpb.2026.115218_b0290","article-title":"Sophorolipid Suppresses LPS-Induced Inflammation in RAW264.7 Cells through the NF-\u03baB Signaling Pathway","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115218_b0295","doi-asserted-by":"crossref","first-page":"546","DOI":"10.21037\/atm-20-2972","article-title":"Ruxolitinib protects lipopolysaccharide (LPS)-induced sepsis through inhibition of nitric oxide production in mice","volume":"8","author":"Li","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejpb.2026.115218_b0300","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8481243","article-title":"Positive Effects against UV-A Induced damage and Oxidative stress on an in Vitro Cell Model using a Hyaluronic Acid based Formulation Containing Amino Acids, Vitamins, and Minerals","volume":"2018","author":"Stellavato","year":"2018","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2026.115218_b0305","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1074\/jbc.M804178200","article-title":"Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes","volume":"284","author":"Grishko","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2026.115218_b0310","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.21037\/tp-23-16","article-title":"Ruxolitinib inhibits the proliferation and induces the apoptosis of MLL-r ALL cells through inactivating JAK\/STAT signaling pathway","volume":"12","author":"Liao","year":"2023","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.ejpb.2026.115218_b0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2012.09.013","article-title":"JAK-STAT pathway modulates the roles of iNOS and COX-2 in the cytoprotection of early phase of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress","volume":"529","author":"Yu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejpb.2026.115218_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114962","article-title":"Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK\/STAT signaling pathway","volume":"161","author":"Yang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2026.115218_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108517","article-title":"Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment","volume":"218","author":"Yeleswaram","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejpb.2026.115218_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119889","article-title":"Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs","volume":"590","author":"Persaud","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115218_b0335","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/CCID.S116995","article-title":"Effectiveness of topical peppermint oil on symptomatic treatment of chronic pruritus","volume":"9","author":"Elsaie","year":"2016","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115218_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.620098","article-title":"Ruxolitinib Cream has dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis","volume":"11","author":"Scuron","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115218_b0345","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2024.12464","article-title":"PJ\u2011001, a small\u2011molecule proteolysis\u2011targeting chimera, ameliorates atopic dermatitis\u2011like inflammation in mice by inhibiting the JAK2\/STAT3 pathway and repairing the skin barrier","volume":"27","author":"Lin","year":"2024","journal-title":"Exp. Ther. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:47:16Z","timestamp":1791024436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":69,"alternative-id":["S0939641126002390"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115218","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted topical delivery of Ruxolitinib-Loaded nanoemulgel for potential management of Atopic Dermatitis: An integrated in silico, in vitro, and in vivo approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115218"}}